CEREGARD PLUS

Indications

• Acute ischemic stroke
• Traumatic brain injury
• Neurodegenerative disorders
• Cognitive impairment

Dosage

Children: Refer to specific clinical guidelines or consult a healthcare professional for dosing information.

Adults: Refer to specific clinical guidelines or consult a healthcare professional for dosing information.

Mechanism of action

Cerebroprotein is believed to exert its effects by modulating neurotrophic factors and enhancing synaptic plasticity. It may promote neuronal survival through its influence on cell signaling pathways that regulate apoptosis and cellular repair mechanisms.

Pharmacodynamics

Cerebroprotein demonstrates neuroprotective properties, promoting neuronal health and function. It may enhance cognitive functions and improve memory through its actions on neurotransmitter systems, particularly in conditions associated with neuronal damage.

Pharmacokinetics

The pharmacokinetics of cerebroprotein are not thoroughly characterized in the literature, but it is generally administered parenterally. Its distribution, metabolism, and elimination have not been well-defined due to the complexity of its biological origin.

Pregnancy

Cerebroprotein should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult health care providers for guidance.

Breast-feeding

There is limited information on the excretion of cerebroprotein in human breast milk. Caution is advised when administering to nursing mothers.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Cognitive impairment
• Stroke rehabilitation
• Alzheimer's disease
• Head trauma
• Age-related cognitive decline

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in paediatric populations.

Adults: Refer to the BNF for appropriate dosing in adults, as it may vary based on the condition being treated.

Mechanism of action

Citicoline serves as a precursor for the synthesis of phosphatidylcholine, a major component of neuronal membranes. It is metabolized into choline and cytidine, both of which contribute to the regeneration of damaged neuronal membranes and promote the release of neurotransmitters. The enhancement of dopaminergic neurotransmission and neuroprotective effects against ischemia and excitotoxicity are also attributed to citicoline.

Pharmacodynamics

Citicoline has been shown to enhance memory and cognitive function, particularly in patients with cognitive deficits. It exerts neuroprotective effects by stabilizing cell membranes, promoting neuronal repair, and enhancing synaptic plasticity. Clinical studies have suggested improvements in attention, memory, and overall cognitive performance in various populations, including those with Alzheimer's disease and stroke.

Pharmacokinetics

Citicoline is well-absorbed following oral administration, with peak plasma concentrations achieved within 1-2 hours. It is rapidly metabolized into its active components, choline and cytidine. The elimination half-life of citicoline is approximately 3 hours, and it is primarily excreted through urine. The drug has good bioavailability and can cross the blood-brain barrier, making it effective for central nervous system conditions.

Adverse effects

• headache
• nausea
• diarrhea
• insomnia
• abdominal pain

Precautions

• Use with caution in patients with a history of hypersensitivity to citicoline or any of its components.
• Monitor patients with a history of seizures.

Pregnancy

Citicoline should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There is limited data on its safety in pregnancy.

Breast-feeding

Citicoline is excreted in human milk; caution should be exercised when administered to nursing women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• oral tablets
• oral solution

Indications

• Nutritional support in malnourished patients
• Post-operative recovery
• Management of malabsorption syndromes
• Support in conditions requiring enhanced protein intake

Dosage

Children: Refer to the BNF for Children for dosing recommendations.

Adults: Refer to specific formulations and BNF guidelines for appropriate dosing.

Mechanism of action

Hydrolysates increase the availability of amino acids and peptides for absorption in the intestines. The smaller size of these molecules compared to whole proteins facilitates their transport across the intestinal wall, allowing for quicker and more effective utilization by the body. This mechanism is particularly beneficial in patients with compromised digestive capabilities.

Pharmacodynamics

The pharmacodynamic effects of hydrolysates involve the supply of essential and non-essential amino acids, which are crucial for various metabolic processes, including protein synthesis, neurotransmitter production, and immune function. The rapid absorption of these peptides can lead to quicker recovery times in malnourished individuals or those undergoing surgical recovery.

Pharmacokinetics

Hydrolysates are rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations occurring shortly after ingestion. The bioavailability of amino acids from hydrolysates is generally higher than that of intact proteins due to their smaller molecular size. The metabolism of amino acids occurs primarily in the liver, where they can be utilized for energy production or incorporated into new proteins. The elimination of amino acids happens through renal pathways, with excess being excreted in urine.

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if hydrolysate is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.